1. Home
  2. RDWR vs ALVO Comparison

RDWR vs ALVO Comparison

Compare RDWR & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Radware Ltd.

RDWR

Radware Ltd.

HOLD

Current Price

$29.64

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Logo Alvotech

ALVO

Alvotech

HOLD

Current Price

$5.86

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RDWR
ALVO
Founded
1996
2013
Country
Israel
Luxembourg
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.0B
IPO Year
2000
2021

Fundamental Metrics

Financial Performance
Metric
RDWR
ALVO
Price
$29.64
$5.86
Analyst Decision
Buy
Buy
Analyst Count
2
4
Target Price
$32.50
$8.00
AVG Volume (30 Days)
197.9K
1.1M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$10.65
$13.28
Revenue Next Year
$8.62
$18.63
P/E Ratio
$59.76
$18.20
Revenue Growth
N/A
N/A
52 Week Low
$21.68
$2.94
52 Week High
$32.79
$9.05

Technical Indicators

Market Signals
Indicator
RDWR
ALVO
Relative Strength Index (RSI) 51.26 70.04
Support Level $26.61 $3.10
Resistance Level $29.66 $5.85
Average True Range (ATR) 1.11 0.25
MACD 0.11 0.02
Stochastic Oscillator 36.45 76.04

Price Performance

Historical Comparison
RDWR
ALVO

About RDWR Radware Ltd.

Radware Ltd is a provider of application security and delivery solutions for multi-cloud environments. Its solutions secure the digital experience by providing infrastructure, application, and network protection and availability services to companies globally. Its solutions are deployed by, among others, enterprises, carriers, and cloud service providers. The company offers solutions in two main categories: Products offers a range of cloud-based security-as-a-service subscriptions, on-premises hardware and software products, and product subscriptions (or a combination of these) to customers; and Services offers managed services, professional services, technical support and training and certification to customers and partners.

About ALVO Alvotech

Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.

Share on Social Networks: